Eradivir
San Diego, United States· Est.
Eradivir develops antibody-recruiting molecules that selectively target diseased cells and activate a precise immune response to eliminate them.
Private Company
Funding information not available
About
Eradivir develops antibody-recruiting molecules that selectively target diseased cells and activate a precise immune response to eliminate them.
Small Molecules